Thanks for sharing! I have read this article and i
Post# of 145190
One thing I recall and pertains to the CAR-T deletion of CCR5 is this was viewed positively, and thus I was concerned about it being a competitor to leronlimab (when doing my earlier DD). I know these will take quite a bit more time for approval if that ever happens, so I didn’t let that keep me from pursuing CYDY.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)